Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2016-12-02 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 November 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/11/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting monthly share capital movements for a listed issuer. The document is not an annual or interim report, earnings release, or management discussion. It is a regulatory announcement of share capital movements, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change (SHA) because it is a monthly return report rather than a single announcement of a capital change event.
2016-12-02 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 October 2016
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a Major Shareholding Notification or Share Issue/Capital Change. However, since it covers detailed monthly movements in securities and share capital, it aligns best with Share Issue/Capital Change (SHA) filings, which cover announcements regarding new share issues, stock splits, or other capital changes. The document is not an announcement of a report but a detailed monthly return, and it is not a certification or attestation. Therefore, the appropriate classification is SHA with high confidence.
2016-11-02 English
CONNECTED TRANSACTION ESTABLISHMENT OF LIMITED PARTNERSHIP
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular addressed to shareholders of Overseas Chinese Town (Asia) Holdings Limited regarding a connected transaction for the establishment of a limited partnership. It includes detailed information about the transaction, parties involved, capital contributions, and regulatory compliance with the Listing Rules. The document is structured as a shareholder circular with letters from the board, independent board committee, and financial adviser, typical of materials sent to shareholders to inform and seek approval for significant corporate actions. It is not a financial report, earnings release, or regulatory filing but a proxy solicitation type document providing information for shareholder decision-making on a specific transaction. Therefore, it fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full circular, not just an announcement or report publication notice.
2016-10-26 English
DELAY IN DESPATCH OF CIRCULAR
Report Publication Announcement Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a delay in the despatch of a circular related to a Limited Partnership Agreement and associated transactions. It references previous announcements and states that the circular, which contains detailed information and recommendations, will be sent later than originally planned. The document is short (2185 characters) and serves as a notification about the timing of a report (the circular), not the report itself. Therefore, it fits the criteria for a Report Publication Announcement (RPA) rather than the actual detailed report or financial document.
2016-10-24 English
UPDATE OF DISCLOSEABLE AND CONNECTED TRANSACTION ESTABLISHMENT OF LIMITED PARTNERSHIP
Capital/Financing Update Classification · 95% confidence The document is an announcement related to an update on a discloseable and connected transaction concerning the establishment of a limited partnership. It references a previous announcement and discusses shareholder approvals and waivers from holding a general meeting. The content is focused on corporate transaction updates and compliance with listing rules, without containing financial statements or detailed financial data. The document length is short (2765 characters) and it is clearly an announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a transaction affecting the company's capital structure and shareholder approvals.
2016-10-11 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 30 September 2016
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2016, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share capital changes. The content is focused on share capital changes and movements during a specific month, which aligns with regulatory reporting requirements for share capital movements. It is not a full financial report, earnings release, or management discussion. It is a regulatory filing reporting share capital movements for a specific period, typical of a regulatory compliance document rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2016-10-03 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.